
Josh Wolf
@joshuawolf
Pediatrician, Infectious Diseases Physician and Researcher @StJudeResearch. Views are my own.
ID: 29945430
https://www.stjude.org/directory/w/joshua-wolf.html 09-04-2009 08:04:59
2,2K Tweet
1,1K Followers
549 Following



Okay 𝒌𝒆𝒗𝒊𝒏 𝒌𝒆𝒍𝒍𝒆𝒓, you asked for a combo Abx therapy rant, so here it comes (I guess Im taking requests now! ;)). There are 3 philosophical reasons to use combination Abx therapy (see my Mandell chapter for this discussion in detail). But they all apply differently to difft dzs.




#IDtwitter Any good studies on combination azole/L-AMB for extensive sino-orbital Mucorales? FungalDoc: moved to bluesky @GermHunterMD Neil Stone Gabe 🦊

BREAKING NEWS. The Global Trial Steering Committee has advised trial sites today that we have closed the PSSA and MSSA silo backbone domains on the advice of the DSMC. We await data to become available for analysis. Steven Tong Joshua Davis Todd C. Lee #IDTwitter #IDX


Am I crazy, or should Chris Hadfield be the next CEO of The Boeing Company ???!?!!


So excited our recent paper got a shoutout in Immunology Podcast! This ongoing research is going to be a fascinating story, because OLAH regulation seems to involve lots of different biological processes like viral replication, inflammation, metabolism, and wound healing. Stay tuned!

After the Black in Cancer conference back in June, we caught up with Sadhana Jackson to talk drug delivery, navigating the blood-brain barrier and the future of cancer treatment for children. Hear her thoughts 👇 Dr. Sadhana Jackson, MD | #CCAM bit.ly/3XqCHSK



Dr Dr. Annie Andrews and I team up to tell the world the why kid’s care and their providers are not valued as highly as adult’s care- do we like kids less than adults??? No! Let’s get serious about changing this system Dr. Glaucomflecken Weill Cornell Pediatrics AMSPDC American Academy of Pediatrics @Their__Future

This is a very exciting and promising new approach that gets folks with orthopedic device infections healing and back on their feet sooner. In kids with cancer, it also allows safe re-initiation of chemotherapy without compromising infection outcomes. St. Jude Research
